About Techcyte
Techcyte is an AI software platform for anatomic and clinical pathology that leverages machine learning for quicker, more efficient diagnoses.
Mission & Story
Mission
Leading digital diagnostics into the future since 2013. Techcyte creates powerful machine learning solutions for cellular and liquid based mediums that are built on a framework of competencies that allow us to augment the work of labs and lab professionals, and to advance the field of digital diagnostics.
Founding Story
Founded in 2013 (as indicated by copyright and 'since 2013' messaging). Specific founder details not provided in scraped content.
Clinical Focus
Medical conditions and clinical areas addressed by Techcyte.
Who It Serves
Milestones & Awards
Recent Milestones
Fusion AP achieved CE-IVDR certification (2025). Unveiled Fusion unified anatomic and clinical digital pathology platform (March 2025). Multiple strategic partnerships announced 2024-2025 including Mayo Clinic Platform, BD, Deep Bio, Mindpeak, Aiosyn, Aiforia, Modella AI, and Pramana.
Key Partnerships
Social & Media
Follow on
Latest Updates
Techcyte in the news
Techcyte Named 2025 Infectious Disease Testing Solution of the Year by BioTech Breakthrough Awards
Techcyte Fusion Anatomic Pathology advances digital pathology transformation at Mayo Clinic
Schedule a Demo
Techcyte Announces Implementation of AI-Powered Parasitology Suite at M Health Fairview
Company Details
- Founded
- 2013
- Headquarters
- Orem, UT, USA
- Employees
- 150
- Stage
- growth
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 45 →
Aiforia
Aiforia provides AI-powered digital pathology solutions for clinical diagnostics and research. The company offers cloud-based deep learning tools and CE-IVD marked clinical suites for analyzing pathology images across multiple cancer types, serving pathologists, researchers, and diagnostic laboratories worldwide.
Aignostics
Aignostics develops AI-powered pathology solutions for precision medicine, specializing in tumor microenvironment analysis from H&E-stained whole slide images. The company serves life sciences companies and academic researchers with foundation models and custom analytics services.
Aiosyn
Aiosyn develops AI-powered computational pathology software that integrates into standard digital pathology workflows. The company specializes in deep learning solutions for cancer and chronic kidney disease diagnostics, serving clinical laboratories, biopharma, and CROs.
AIxMed
AIxMed develops AI-powered computational cytology platforms for cancer detection and diagnosis. The company's flagship product AIxURO analyzes urine cytology for bladder cancer, with additional platforms in development for thyroid, cervical, and lung cancer screening.
Akoya Biosciences
Akoya Biosciences, now part of Quanterix, provides spatial biology solutions for high-plex tissue analysis. The company develops instruments, assays, and software for spatial proteomics research, enabling researchers to map biomarkers at single-cell resolution in tissue samples.
Caris Life Sciences
Caris Life Sciences is a leading precision medicine company that provides comprehensive molecular profiling for cancer patients. The company combines genomic, transcriptomic, and proteomic data with AI to deliver personalized treatment insights for oncologists and patients.
CellaVision
201-500 employees
CellaVision is a world-leading provider of digital hematology microscopy solutions covering analyzers, instruments, reagents, and software. The company automates workflows in hematology laboratories of all sizes for human and animal blood and body fluid sample analysis.
Clever Culture Systems
Clever Culture Systems develops AI-powered automated microbiology culture plate reading technology for pharmaceutical and clinical laboratories. Their flagship product, APAS Independence, automates the imaging, interpretation, and reporting of microbial growth on culture plates.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.